Form 8-K - Current report:
SEC Accession No. 0000950170-25-071966
Filing Date
2025-05-15
Accepted
2025-05-15 07:05:04
Documents
13
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K caba-20250515.htm   iXBRL 8-K 52711
2 EX-99.1 caba-ex99_1.htm EX-99.1 37917
3 GRAPHIC img132663336_0.jpg GRAPHIC 6003
  Complete submission text file 0000950170-25-071966.txt   226504

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20250515.xsd EX-101.SCH 26027
15 EXTRACTED XBRL INSTANCE DOCUMENT caba-20250515_htm.xml XML 4937
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 25948640
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)